Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 1
1981 1
1982 1
1985 3
1986 1
1987 5
1988 1
1992 2
1994 3
1995 2
1996 1
1997 1
1998 1
1999 7
2000 9
2001 1
2002 1
2003 3
2004 11
2005 8
2006 18
2007 29
2008 25
2009 34
2010 46
2011 45
2012 73
2013 84
2014 87
2015 98
2016 99
2017 124
2018 156
2019 149
2020 192
2021 228
2022 24
Text availability
Article attribute
Article type
Publication date

Search Results

1,402 results
Results by year
Filters applied: . Clear all
Page 1
Dominant subtype switch in avian influenza viruses during 2016-2019 in China.
Bi Y, Li J, Li S, Fu G, Jin T, Zhang C, Yang Y, Ma Z, Tian W, Li J, Xiao S, Li L, Yin R, Zhang Y, Wang L, Qin Y, Yao Z, Meng F, Hu D, Li D, Wong G, Liu F, Lv N, Wang L, Fu L, Yang Y, Peng Y, Ma J, Sharshov K, Shestopalov A, Gulyaeva M, Gao GF, Chen J, Shi Y, Liu WJ, Chu D, Huang Y, Liu Y, Liu L, Liu W, Chen Q, Shi W. Bi Y, et al. Among authors: yin r. Nat Commun. 2020 Nov 20;11(1):5909. doi: 10.1038/s41467-020-19671-3. Nat Commun. 2020. PMID: 33219213 Free PMC article.
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial.
Wu XH, Zhu JQ, Yin RT, Yang JX, Liu JH, Wang J, Wu LY, Liu ZL, Gao YN, Wang DB, Lou G, Yang HY, Zhou Q, Kong BH, Huang Y, Chen LP, Li GL, An RF, Wang K, Zhang Y, Yan XJ, Lu X, Lu WG, Hao M, Wang L, Cui H, Chen QH, Abulizi G, Huang XH, Tian XF, Wen H, Zhang C, Hou JM, Mirza MR. Wu XH, et al. Among authors: yin rt. Ann Oncol. 2021 Apr;32(4):512-521. doi: 10.1016/j.annonc.2020.12.018. Epub 2021 Jan 14. Ann Oncol. 2021. PMID: 33453391 Free article. Clinical Trial.
Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells via a KDM4C-ALKBH5-AXL Signaling Axis.
Wang J, Li Y, Wang P, Han G, Zhang T, Chang J, Yin R, Shan Y, Wen J, Xie X, Feng M, Wang Q, Hu J, Cheng Y, Zhang T, Li Y, Gao Z, Guo C, Wang J, Liang J, Cui M, Gao K, Chai J, Liu W, Cheng H, Li L, Zhou F, Liu L, Luo Y, Li S, Zhang H. Wang J, et al. Among authors: yin r. Cell Stem Cell. 2020 Jul 2;27(1):81-97.e8. doi: 10.1016/j.stem.2020.04.001. Epub 2020 May 12. Cell Stem Cell. 2020. PMID: 32402251 Free article.
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial.
Zhong WZ, Wang Q, Mao WM, Xu ST, Wu L, Wei YC, Liu YY, Chen C, Cheng Y, Yin R, Yang F, Ren SX, Li XF, Li J, Huang C, Liu ZD, Xu S, Chen KN, Xu SD, Liu LX, Yu P, Wang BH, Ma HT, Yang JJ, Yan HH, Yang XN, Liu SY, Zhou Q, Wu YL. Zhong WZ, et al. Among authors: yin r. J Clin Oncol. 2021 Mar 1;39(7):713-722. doi: 10.1200/JCO.20.01820. Epub 2020 Dec 17. J Clin Oncol. 2021. PMID: 33332190 Clinical Trial.
1,402 results